LC
ASXC

Landaas & Company’s Asensus Surgical, Inc. ASXC Stock Holding History

Landaas & Company’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-77
Closed -$4K – 326
2018
Q2 		$4K Buy
+77
New +$2.81K ﹤0.01% 311
2018
Q1 		– Sell
-77
Closed -$2K – 322
2017
Q4 		$2K Buy
+77
New +$2.37K ﹤0.01% 321

Other funds holding ASXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Landaas & Company's ASXC Position: Q3 2018 in Review

Landaas & Company sold out of Asensus Surgical, Inc. (ASXC) in Q3 2018, closing a stake of 77 shares — an estimated $4K sold.

Landaas & Company first reported a position in ASXC in Q4 2017 and held it in 2 quarters. The position peaked at $4K in Q2 2018. 151 funds tracked by Wall St. Rank hold ASXC as of Q3 2018.

  • Landaas & Company reported no remaining Asensus Surgical, Inc. position as of Q3 2018 after selling out during the quarter.
  • Landaas & Company sold 77 Asensus Surgical, Inc. shares in Q3 2018, an estimated $4K.
  • Landaas & Company first reported a position in Asensus Surgical, Inc. in Q4 2017 and held it in 2 quarters.
  • Landaas & Company's Asensus Surgical, Inc. position peaked at $4K in Q2 2018.
  • 151 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2018.

Based on Landaas & Company's 13F filing for Q3 2018, filed 14 Nov 2018.